4th Quarter - Report
PHARMATHENE, INC for PHARMATHENE, INC
Firm
Client
Income
—
Expenses
$177,386
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pandemic All-Hazards preparedness Act (PAHPA) Reauthorization; Biomedical Advanced Research and Development Authority (BARDA) funding at HHS for 2011; Education on threat of bioterrorism and urgency for development of Medical Countermeasures (MCM's) including new, modern recombinant Protective Antigen anthrax vaccine (rPA), anthrax antitoxin monoclonal antibody therapeutic and chemical nerve agent bioscavenger.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK EDWARD COOKE | Sr. Director Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.